The platform enables clinicians to tailor GLP-1 titration at scale, aiming to reduce discontinuation rates and improve ...

The long-term goal of a fully automated insulin delivery (AID) system that operates without user input to maintain glucose levels within target range remains a future aspiration and may never be fully ...

UK medtech firm Closed Loop Medicine has launched its first product in the US, a digital tool for personalising the dose of ...

Until now, the effect of insulin delivery in hybrid closed-loop systems on the risk of acute diabetes complications in people with type 1 diabetes has been unclear. Researchers have therefore now ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies*, insulin administration is manually controlled, while hybrid ...

Palladyne AI’s flagship platform, Palladyne IQ, is redefining what robots can automate. By combining edge-based closed-loop AI with no-code programming, the system enables robots to adapt to real-time ...

Closed Loop Medicine Ltd (CLM), a leader in personalized pharmaceutical dosing, today announced the U.S. launch of WeDosify, which enables clinicians to personalize GLP-1 titration at scale.